Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Seamless Design Clinical Trial of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B

NCT07203118 is registered in ClinicalTrials.gov with Xi'an Xintong Pharmaceutical Research Co.,Ltd. as lead sponsor.

NCT NCT07203118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Seamless Design Clinical Trial of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
Lead sponsor
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
July 1, 2025
Completion date
February 28, 2030
Enrollment
1,444 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b